BA-215

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBA-215
Drug Alias NameBA-215
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionRhodopsin inhibitors
TargetsRhodopsin
Therapy Area/IndicationsBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioaxone
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioaxone
Active IndicationsN/A
Inactive IndicationsBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A